Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India
Takeda’s Qdenga has become the first dengue vaccine to receive official approval in India for use among residents aged 4 to 60.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Drug Controller General of India (DCGI) has granted approval for the use of the Qdenga vaccine, manufactured by the Japanese pharmaceutical company Takeda. The vaccine is indicated for individuals between the ages of 4 and 60.
Coverage from Reuters, The Hindu, The Indian Express, NDTV, and The Times of India emphasizes the scope of the approval and the vaccine's eligibility requirements. Media reports also highlight that a private university located in a city conducted chemical trials related to the vaccine.
Future developments will depend on the implementation of the vaccine rollout. Current coverage does not yet specify the timeline for public availability or distribution protocols for the newly approved treatment.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4h ago.
Quick answers
Who is eligible to receive the Qdenga vaccine?
The vaccine is approved for individuals aged 4 to 60 years.
Which organization approved the vaccine?
The Drug Controller General of India (DCGI) granted the approval.
What is the origin of the vaccine?
Qdenga is produced by the Japanese drugmaker Takeda.
Coverage (8)
- Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations Taiwan News · 1d ago
- India approves first dengue vaccine as cases surge in South Asia The Telegraph · 1d ago
- City-based pvt varsity conducted dengue vaccine’s chemical trial The Times of India · 1d ago
- India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained NDTV · 1d ago
- India approves first dengue vaccine for individuals aged 4 to 60 years The Hindu · 1d ago
- India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60 The Indian Express · 1d ago
- India approves dengue vaccine: Doctor explains the four virus strains and why immunity remains a major challenge The Times of India · 1d ago
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India Reuters · 1d ago
Topics
Related trends
Sri Lanka uses air force drones to tackle spreading dengue outbreak
Sri Lanka is deploying air force drones to combat a surge in dengue fever cases as authorities intensify legal action against site owners.
Police attack Cockroach activists as thousands march on Indian parliament
Indian police have deployed tear gas against thousands of Cockroach movement supporters marching toward the parliament in New Delhi.
Police in India Use Tear Gas and Batons on Crowds Protesting Exam Scandal
Protesters in Delhi face police force as demonstrations against an exam scandal intensify near the Indian parliament.
Russian attack on corn ship off Ukraine's Odesa kills 10
A Russian strike on a merchant ship near Odesa has resulted in 10 deaths, including four Indian nationals, prompting a formal diplomatic response.
India's Gen Z 'Cockroach People's Party' started as satire but is serious about change
India's Gen Z-led Cockroach People's Party, or Cockroach Janta, is shifting from satirical origins to active political mobilization.
Why have India’s Gen Z protesters called for a march to parliament?
Protesters from the Cockroach Janta Party have gathered in Delhi, signaling intent to march to parliament despite police-imposed bans on large gatherings.